333 related articles for article (PubMed ID: 3133978)
1. Serum antibodies to gangliosides in Guillain-Barré syndrome.
Ilyas AA; Willison HJ; Quarles RH; Jungalwala FB; Cornblath DR; Trapp BD; Griffin DE; Griffin JW; McKhann GM
Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
4. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
Kusunoki S; Chiba A; Kon K; Ando S; Arisawa K; Tate A; Kanazawa I
Ann Neurol; 1994 May; 35(5):570-6. PubMed ID: 8179303
[TBL] [Abstract][Full Text] [Related]
5. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
7. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
10. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
Kusunoki S; Kaida K
J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
[TBL] [Abstract][Full Text] [Related]
14. Anti-ganglioside complex antibodies associated with severe disability in GBS.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
[TBL] [Abstract][Full Text] [Related]
15. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
Kusunoki S
Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
[TBL] [Abstract][Full Text] [Related]
16. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
Carpo M; Nobile-Orazio E; Meucci N; Gamba M; Barbieri S; Allaria S; Scarlato G
Ann Neurol; 1996 Apr; 39(4):539-43. PubMed ID: 8619533
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
Ilyas AA; Cook SD; Mithen FA; Taki T; Kasama T; Handa S; Hamasaki H; Singhal BS; Li SC; Li YT
J Neuroimmunol; 1998 Mar; 82(2):160-7. PubMed ID: 9585812
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
[TBL] [Abstract][Full Text] [Related]
19. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
